Gender Male
LinkedIn View on LinkedIn
Robert Kessler, M.D. is the one of the primary inventors and founders of PharmoRx Therapeutics, Inc. (PTI). Together with Dr. Bear, he founded PTI and patented the invention to develop novel uses of established dopamine-active agents in Neuropsychiatry. Dr. Kessler currently serves as Chief Medical Advisor of PTI.
Dr. Kessler is a
Neuroradiologist with over 30 years of experience in both PET and MRI imaging, both at a clinical and research level. He holds patents both in development of dopamine D2 receptor ligands and in development of MRI pulse sequences.
His PET research has included studies of cerebral metabolism, development of dopaminergic and glutamatergic PET radioligands for CNS neurotransmission, schizophrenia, mechanism of action of antipsychotic drugs, reward function, psychostimulant drug abuse, and obesity. His current interests include the interaction of dopaminergic and glutamatergic neurotransmission in psychiatric and neurological disorders.
In 2013, he joined the UAB faculty as Professor of Radiology and Director of Neurochemical Brain Imaging and PET Neurotracer Development. Previously, he was the Roentgen Professor of Radiology at the Vanderbilt University School of Medicine where he held a number of positions including Director of Neuroradiology and Positron Tomography.
Dr. Kessler attended Yale University as an undergraduate and received his M.D. from Yale School of Medicine. He subsequently joined a lab at the National Institutes of Health as it became the first to use a PET scans to visualize activity of the brain.
